Neuronal-Activity Dependent Mechanisms of Small Cell Lung Cancer Pathogenesis
RNA-seq (gene expression) · human · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Small cell lung cancerThis series is part of our curated briefing on it.
- Samples
- 36 samples: 36 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesisNature · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE303152_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1294240. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 36 sample titles: 36 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9119073 sclc_n3525_3p_sn
- GSM9119075 sclc_n3626_3p_sn
- GSM9119077 sclc_n3628_3p_sn
- GSM9119079 sclc_n3657_3p_sn
- GSM9119081 sclc_ns005_3p_sn
- GSM9119083 sclc_ns007_3p_sn
- GSM9119085 sclc_pa013_5pv2_sn
- GSM9119087 sclc_pa031_5pv2_sn
- GSM9119089 sclc_pa096_3p_sn
- GSM9119091 sclc_pa098_3p_sn
- GSM9119093 sclc_pa124_3p_sn
- GSM9119095 sclc_pa124_5pv2_sn
- GSM9119097 sclc_pa146_3p_sn
- GSM9119099 sclc_pa150_3p_sn
- GSM9119101 sclc_pa151_3p_sn
- GSM9119103 sclc_pa168_3p_sn
- GSM9119105 RU1065C_SCLC_MET_LI_sn
- GSM9119107 RU1066_SCLC_PRI_LU_sn
- GSM9119109 RU1080_SCLC_MET_KID_sn
- GSM9119111 RU1108a_SCLC_REC_LU_b_sn
- GSM9119113 RU1108a_SCLC_REC_LU_bf_sn
- GSM9119115 RU1108a_SCLC_REC_LU_rpmi_sn
- GSM9119117 RU1144_SCLC_MET_LM_sn
- GSM9119119 RU1144_SCLC_REC_LU_sn
- GSM9119121 RU1152_SCLC_MET_LN_sn
- GSM9119123 RU1181_SCLC_MET_LN_sn
- GSM9119125 RU1181_SCLC_PRI_LU_sn
- GSM9119127 RU1195A_SCLC_REC_LU_sn
- GSM9119129 RU1215_SCLC_MET_PL_sn
- GSM9119131 RU1229A_SCLC_PRI_LU_sn
- GSM9119133 RU1231A_SCLC_MET_LN_sn
- GSM9119135 RU1293A_SCLC_MET_LN_sn
- GSM9119137 RU1311_SCLC_REC_LU_sn
- GSM9119139 RU1322_SCLC_MET_LN_sn
- GSM9119141 RU426_SCLC_PRI_LU_sn
- GSM9119143 RU779_SCLC_MET_LI_sn
- GSE303043 UHRF1 drives subtype-independent aggressiveness and immune evasion in small cell lung cancer through GATA2-ST6GALNAC5 and PRC2 interactions 30 samples same disease briefing · shares dependent, small, lung
- GSE297360 Loss of NOTCH2 Creates a TRIM28-Dependent Vulnerability in Small Cell Lung Cancer [human_bulk_RNA_seq] 14 samples same disease briefing · shares dependent, small, lung
- GSE297358 Loss of NOTCH2 Creates a TRIM28-Dependent Vulnerability in Small Cell Lung Cancer [ChIP-seq] 29 samples same disease briefing · shares dependent, small, lung
- GSE280212 Mechanisms of drugs-resistance in small cell lung cancer III 12 samples same disease briefing · shares small, lung
- GSE208446 Small cell lung cancer responds to inhibition of Jumonji enzyme in vitro and in vivo 90 samples same disease briefing · shares small, lung
- GSE255095 An in vivo screening platform using PDX models reveals KEAP1, USP22 and other drivers of chemoresistance in small cell lung cancer 67 samples same disease briefing · shares small, lung
- GSE281525 RNA-sequence data of clinically never-metastatic primary small cell lung cancer cases and small cell lung cancer metastasis cases, FOXA2 knock-down and overexpression in cell lines 61 samples same disease briefing · shares small, lung
- GSE138474 Single-cell analyses reveal increasing intratumoral heterogeneity as an essential component of treatment resistance in small cell lung cancer 43 samples same disease briefing · shares small, lung
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.